Cargando…

In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes

Type 2 diabetes (T2D) is a rising global health problem mainly caused by obesity and a sedentary lifestyle. In healthy individuals, white adipose tissue (WAT) has a relevant homeostatic role in glucose metabolism, energy storage, and endocrine signaling. Mast cells contribute to these functions prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Perez, David, Redruello-Romero, Anaïs, Garcia-Rubio, Jesús, Arana, Carlos, Garcia-Escudero, Luis A., Tamayo, Francisco, Puentes-Pardo, Jose D., Moreno-SanJuan, Sara, Salmeron, Javier, Blanco, Armando, Galvez, Julio, Leon, Josefa, Carazo, Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177010/
https://www.ncbi.nlm.nih.gov/pubmed/34093556
http://dx.doi.org/10.3389/fimmu.2021.664576
_version_ 1783703340832522240
author Lopez-Perez, David
Redruello-Romero, Anaïs
Garcia-Rubio, Jesús
Arana, Carlos
Garcia-Escudero, Luis A.
Tamayo, Francisco
Puentes-Pardo, Jose D.
Moreno-SanJuan, Sara
Salmeron, Javier
Blanco, Armando
Galvez, Julio
Leon, Josefa
Carazo, Ángel
author_facet Lopez-Perez, David
Redruello-Romero, Anaïs
Garcia-Rubio, Jesús
Arana, Carlos
Garcia-Escudero, Luis A.
Tamayo, Francisco
Puentes-Pardo, Jose D.
Moreno-SanJuan, Sara
Salmeron, Javier
Blanco, Armando
Galvez, Julio
Leon, Josefa
Carazo, Ángel
author_sort Lopez-Perez, David
collection PubMed
description Type 2 diabetes (T2D) is a rising global health problem mainly caused by obesity and a sedentary lifestyle. In healthy individuals, white adipose tissue (WAT) has a relevant homeostatic role in glucose metabolism, energy storage, and endocrine signaling. Mast cells contribute to these functions promoting WAT angiogenesis and adipogenesis. In patients with T2D, inflammation dramatically impacts WAT functioning, which results in the recruitment of several leukocytes, including monocytes, that enhance this inflammation. Accordingly, the macrophages population rises as the WAT inflammation increases during the T2D status worsening. Since mast cell progenitors cannot arrive at WAT, the amount of WAT mast cells depends on how the new microenvironment affects progenitor and differentiated mast cells. Here, we employed a flow cytometry-based approach to analyze the number of mast cells from omental white adipose tissue (o-WAT) and subcutaneous white adipose tissue (s-WAT) in a cohort of 100 patients with obesity. Additionally, we measured the number of mast cell progenitors in a subcohort of 15 patients. The cohort was divided in three groups: non-T2D, pre-T2D, and T2D. Importantly, patients with T2D have a mild condition (HbA1c <7%). The number of mast cells and mast cell progenitors was lower in patients with T2D in both o-WAT and s-WAT in comparison to subjects from the pre-T2D and non-T2D groups. In the case of mast cells in o-WAT, there were statistically significant differences between non-T2D and T2D groups (p = 0.0031), together with pre-T2D and T2D groups (p=0.0097). However, in s-WAT, the differences are only between non-T2D and T2D groups (p=0.047). These differences have been obtained with patients with a mild T2D condition. Therefore, little changes in T2D status have a huge impact on the number of mast cells in WAT, especially in o-WAT. Due to the importance of mast cells in WAT physiology, their decrease can reduce the capacity of WAT, especially o-WAT, to store lipids and cause hypoxic cell deaths that will trigger inflammation.
format Online
Article
Text
id pubmed-8177010
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81770102021-06-05 In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes Lopez-Perez, David Redruello-Romero, Anaïs Garcia-Rubio, Jesús Arana, Carlos Garcia-Escudero, Luis A. Tamayo, Francisco Puentes-Pardo, Jose D. Moreno-SanJuan, Sara Salmeron, Javier Blanco, Armando Galvez, Julio Leon, Josefa Carazo, Ángel Front Immunol Immunology Type 2 diabetes (T2D) is a rising global health problem mainly caused by obesity and a sedentary lifestyle. In healthy individuals, white adipose tissue (WAT) has a relevant homeostatic role in glucose metabolism, energy storage, and endocrine signaling. Mast cells contribute to these functions promoting WAT angiogenesis and adipogenesis. In patients with T2D, inflammation dramatically impacts WAT functioning, which results in the recruitment of several leukocytes, including monocytes, that enhance this inflammation. Accordingly, the macrophages population rises as the WAT inflammation increases during the T2D status worsening. Since mast cell progenitors cannot arrive at WAT, the amount of WAT mast cells depends on how the new microenvironment affects progenitor and differentiated mast cells. Here, we employed a flow cytometry-based approach to analyze the number of mast cells from omental white adipose tissue (o-WAT) and subcutaneous white adipose tissue (s-WAT) in a cohort of 100 patients with obesity. Additionally, we measured the number of mast cell progenitors in a subcohort of 15 patients. The cohort was divided in three groups: non-T2D, pre-T2D, and T2D. Importantly, patients with T2D have a mild condition (HbA1c <7%). The number of mast cells and mast cell progenitors was lower in patients with T2D in both o-WAT and s-WAT in comparison to subjects from the pre-T2D and non-T2D groups. In the case of mast cells in o-WAT, there were statistically significant differences between non-T2D and T2D groups (p = 0.0031), together with pre-T2D and T2D groups (p=0.0097). However, in s-WAT, the differences are only between non-T2D and T2D groups (p=0.047). These differences have been obtained with patients with a mild T2D condition. Therefore, little changes in T2D status have a huge impact on the number of mast cells in WAT, especially in o-WAT. Due to the importance of mast cells in WAT physiology, their decrease can reduce the capacity of WAT, especially o-WAT, to store lipids and cause hypoxic cell deaths that will trigger inflammation. Frontiers Media S.A. 2021-05-21 /pmc/articles/PMC8177010/ /pubmed/34093556 http://dx.doi.org/10.3389/fimmu.2021.664576 Text en Copyright © 2021 Lopez-Perez, Redruello-Romero, Garcia-Rubio, Arana, Garcia-Escudero, Tamayo, Puentes-Pardo, Moreno-SanJuan, Salmeron, Blanco, Galvez, Leon and Carazo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Lopez-Perez, David
Redruello-Romero, Anaïs
Garcia-Rubio, Jesús
Arana, Carlos
Garcia-Escudero, Luis A.
Tamayo, Francisco
Puentes-Pardo, Jose D.
Moreno-SanJuan, Sara
Salmeron, Javier
Blanco, Armando
Galvez, Julio
Leon, Josefa
Carazo, Ángel
In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes
title In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes
title_full In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes
title_fullStr In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes
title_full_unstemmed In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes
title_short In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes
title_sort in patients with obesity, the number of adipose tissue mast cells is significantly lower in subjects with type 2 diabetes
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177010/
https://www.ncbi.nlm.nih.gov/pubmed/34093556
http://dx.doi.org/10.3389/fimmu.2021.664576
work_keys_str_mv AT lopezperezdavid inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT redruelloromeroanais inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT garciarubiojesus inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT aranacarlos inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT garciaescuderoluisa inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT tamayofrancisco inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT puentespardojosed inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT morenosanjuansara inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT salmeronjavier inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT blancoarmando inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT galvezjulio inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT leonjosefa inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes
AT carazoangel inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes